Capricor Therapeutics, Inc. SEC filings CAPR
Capricor Therapeutics, Inc. has 963 filings in SEC EDGAR's recent list, going back to Feb 7, 2001. Its latest annual report, Form ARS, was filed on Apr 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 24, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 14, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Sep 14, 2026 | — |
| 8-K |
Current report
Other events
|
Aug 24, 2026 | Aug 24, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 19, 2026 | — |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| 8-K |
Current report
Results of operations
|
Aug 13, 2026 | Aug 13, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 7, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 3, 2026 | — |
| 8-K |
Current report
Other events
|
Jul 30, 2026 | Jul 29, 2026 |
| 8-K |
Current report
Other events
|
Jul 29, 2026 | Jul 29, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Jul 14, 2026 | Jul 9, 2026 |
| 4 | Insider transaction | Jun 29, 2026 | Jun 25, 2026 |
| 4 | Insider transaction | Jun 29, 2026 | Jun 25, 2026 |
| 8-K |
Current report
Other events
|
Jun 26, 2026 | Jun 26, 2026 |
| 4 | Insider transaction | Jun 24, 2026 | Jun 22, 2026 |
| 4 | Insider transaction | Jun 24, 2026 | Jun 22, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 8, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | May 28, 2026 | May 26, 2026 |
| 3 | Initial insider ownership | May 28, 2026 | May 25, 2026 |
| 4 | Insider transaction | May 19, 2026 | May 18, 2026 |
| 144/A | Filing | May 19, 2026 | — |
| 144 | Notice of proposed sale | May 19, 2026 | — |
| 4 | Insider transaction | May 14, 2026 | May 13, 2026 |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 12, 2026 | May 12, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 7, 2026 | May 7, 2026 |
| 4 | Insider transaction | May 4, 2026 | May 1, 2026 |
| 4 | Insider transaction | May 4, 2026 | May 1, 2026 |
| ARS | Annual report to shareholders | Apr 10, 2026 | Dec 31, 2025 |
| DEF 14A | Proxy statement | Apr 10, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | Apr 3, 2026 | Apr 2, 2026 |
| 144 | Notice of proposed sale | Apr 2, 2026 | — |
| 4 | Insider transaction | Apr 1, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | Apr 1, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | Apr 1, 2026 | Mar 31, 2026 |
| PRE 14A | Preliminary proxy statement | Mar 31, 2026 | May 22, 2025 |
| 144 | Notice of proposed sale | Mar 31, 2026 | — |
| 144 | Notice of proposed sale | Mar 31, 2026 | — |
| 144 | Notice of proposed sale | Mar 31, 2026 | — |
| 4 | Insider transaction | Mar 27, 2026 | Dec 30, 2025 |
| 10-K | Annual report | Mar 17, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 12, 2026 | Mar 12, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 10, 2026 | Mar 10, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 26, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| S-8 | Employee stock plan registration | Jan 30, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 26, 2026 | — |
| 4 | Insider transaction | Jan 7, 2026 | Jan 5, 2026 |
| 4 | Insider transaction | Jan 7, 2026 | Jan 5, 2026 |
| 4 | Insider transaction | Jan 7, 2026 | Jan 5, 2026 |
| 4 | Insider transaction | Jan 7, 2026 | Jan 5, 2026 |
| 4 | Insider transaction | Jan 7, 2026 | Jan 5, 2026 |
| 4 | Insider transaction | Jan 7, 2026 | Jan 5, 2026 |
| 4 | Insider transaction | Jan 7, 2026 | Jan 5, 2026 |
| 4 | Insider transaction | Jan 7, 2026 | Jan 5, 2026 |
| 4 | Insider transaction | Jan 7, 2026 | Jan 5, 2026 |
| 4 | Insider transaction | Jan 7, 2026 | Jan 5, 2026 |
| 4 | Insider transaction | Dec 23, 2025 | Dec 19, 2025 |
| 424B5 | Prospectus supplement | Dec 5, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 5, 2025 | Dec 5, 2025 |
| 424B3 | Prospectus | Dec 5, 2025 | — |
| 424B5 | Prospectus supplement | Dec 4, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 3, 2025 | Dec 3, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 3, 2025 | Dec 3, 2025 |
| 10-Q | Quarterly report | Nov 10, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2025 | Nov 10, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 30, 2025 | — |
| EFFECT | Filing | Sep 23, 2025 | — |
| CORRESP | Letter to the SEC | Sep 19, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 16, 2025 | — |
| S-3 | Shelf registration | Sep 10, 2025 | — |
| 10-Q | Quarterly report | Aug 11, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2025 | Aug 11, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 29, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 11, 2025 | Jul 11, 2025 |
| S-8 | Employee stock plan registration | Jun 16, 2025 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 27, 2025 | May 22, 2025 |
| 10-Q | Quarterly report | May 14, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 13, 2025 | May 13, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 30, 2025 | — |
| ARS | Annual report to shareholders | Apr 9, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Apr 8, 2025 | May 22, 2025 |
| 8-K |
Current report
Officer or director change
|
Apr 8, 2025 | Apr 8, 2025 |
| 10-K | Annual report | Mar 26, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 19, 2025 | Mar 19, 2025 |
| 4 | Insider transaction | Mar 5, 2025 | Mar 3, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Mar 3, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Mar 3, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Mar 3, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 4, 2025 | Mar 4, 2025 |
| 4 | Insider transaction | Feb 28, 2025 | Feb 27, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 5, 2025 | — |
| S-8 | Employee stock plan registration | Feb 5, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 30, 2025 | — |
| 4 | Insider transaction | Jan 6, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 6, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 6, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 6, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 6, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 6, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 6, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 6, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 6, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 6, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 6, 2025 | Jan 2, 2025 |
| 8-K |
Current report
Other events
|
Jan 2, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Dec 16, 2024 | Dec 13, 2024 |
| 4 | Insider transaction | Dec 4, 2024 | Dec 2, 2024 |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2024 | Nov 13, 2024 |
| SC 13G | Ownership over 5% (passive) | Nov 12, 2024 | — |
| EFFECT | Filing | Nov 8, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 8, 2024 | — |
| CORRESP | Letter to the SEC | Nov 6, 2024 | — |
| UPLOAD | Letter from the SEC | Oct 28, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Oct 24, 2024 | — |
| S-3 | Shelf registration | Oct 22, 2024 | — |
| 424B5 | Prospectus supplement | Oct 17, 2024 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Oct 17, 2024 | Oct 16, 2024 |
| EFFECT | Filing | Oct 16, 2024 | — |
| 424B5 | Prospectus supplement | Oct 16, 2024 | — |
| 8-K |
Current report
Results of operations, Other events
|
Oct 16, 2024 | Oct 16, 2024 |
| CORRESP | Letter to the SEC | Oct 16, 2024 | — |
| S-3/A | Filing | Oct 16, 2024 | — |
| CORRESP | Letter to the SEC | Oct 15, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 9, 2024 | Oct 9, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Sep 24, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 24, 2024 | Sep 24, 2024 |
| 4 | Insider transaction | Sep 24, 2024 | Sep 20, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Sep 17, 2024 | Sep 16, 2024 |
| 3 | Initial insider ownership | Aug 23, 2024 | Apr 3, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Aug 23, 2024 | — |
| 4 | Insider transaction | Aug 9, 2024 | Aug 7, 2024 |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2024 | Aug 7, 2024 |
| UPLOAD | Letter from the SEC | Jun 21, 2024 | — |
| S-3 | Shelf registration | Jun 14, 2024 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
May 15, 2024 | May 14, 2024 |
| 8-K |
Current report
Shareholder vote results
|
May 15, 2024 | May 14, 2024 |
| 10-Q | Quarterly report | May 14, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 13, 2024 | May 13, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 29, 2024 | Apr 29, 2024 |
| 4 | Insider transaction | Apr 25, 2024 | Apr 23, 2024 |
| 4 | Insider transaction | Apr 24, 2024 | Apr 23, 2024 |
| ARS | Annual report to shareholders | Apr 1, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Apr 1, 2024 | May 14, 2024 |
| PRE 14A | Preliminary proxy statement | Mar 20, 2024 | May 14, 2024 |
| 10-K | Annual report | Mar 11, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 29, 2024 | Feb 29, 2024 |
| S-8 | Employee stock plan registration | Feb 16, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 7, 2024 | — |
| 8-K |
Current report
Other events
|
Jan 11, 2024 | Jan 11, 2024 |
| 4 | Insider transaction | Jan 4, 2024 | Jan 2, 2024 |
| 4 | Insider transaction | Jan 4, 2024 | Jan 2, 2024 |
| 4 | Insider transaction | Jan 4, 2024 | Jan 2, 2024 |
| 4 | Insider transaction | Jan 4, 2024 | Jan 2, 2024 |
| 4 | Insider transaction | Jan 4, 2024 | Jan 2, 2024 |
| 4 | Insider transaction | Jan 4, 2024 | Jan 2, 2024 |
| 4 | Insider transaction | Jan 4, 2024 | Jan 2, 2024 |
| 4 | Insider transaction | Jan 4, 2024 | Jan 2, 2024 |
| 4 | Insider transaction | Jan 4, 2024 | Jan 2, 2024 |
| 4 | Insider transaction | Jan 4, 2024 | Jan 2, 2024 |
| 4 | Insider transaction | Jan 4, 2024 | Jan 2, 2024 |
| 8-K |
Current report
Other events
|
Dec 11, 2023 | Dec 11, 2023 |
| 10-Q | Quarterly report | Nov 14, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2023 | Nov 14, 2023 |
| 4 | Insider transaction | Oct 24, 2023 | Oct 23, 2023 |
| SC 13G | Ownership over 5% (passive) | Oct 17, 2023 | — |
| 4 | Insider transaction | Oct 13, 2023 | Oct 12, 2023 |
| 4 | Insider transaction | Oct 12, 2023 | Oct 10, 2023 |
| 4 | Insider transaction | Oct 11, 2023 | Oct 9, 2023 |
| 4 | Insider transaction | Oct 10, 2023 | Oct 6, 2023 |
| 4 | Insider transaction | Oct 6, 2023 | Oct 4, 2023 |
| 424B5 | Prospectus supplement | Sep 29, 2023 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Sep 29, 2023 | Sep 29, 2023 |
| FWP | Free writing prospectus | Sep 29, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 29, 2023 | Sep 29, 2023 |
| 4 | Insider transaction | Sep 6, 2023 | Sep 1, 2023 |
| 3 | Initial insider ownership | Sep 6, 2023 | Sep 1, 2023 |
| 8-K |
Current report
Officer or director change
|
Sep 6, 2023 | Sep 1, 2023 |
| 4 | Insider transaction | Aug 16, 2023 | Aug 14, 2023 |
| 10-Q | Quarterly report | Aug 8, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2023 | Aug 7, 2023 |
| 4 | Insider transaction | Jul 24, 2023 | Jul 21, 2023 |
| 3 | Initial insider ownership | Jul 24, 2023 | Jul 21, 2023 |
| 8-K |
Current report
Officer or director change
|
Jul 24, 2023 | Jul 21, 2023 |
| 4 | Insider transaction | Jul 13, 2023 | Jul 11, 2023 |
| 3 | Initial insider ownership | Jul 13, 2023 | Jul 11, 2023 |
| 8-K |
Current report
Officer or director change
|
Jul 13, 2023 | Jul 11, 2023 |
| 8-K/A |
Amended current report
Bylaw or fiscal year change
|
Jun 15, 2023 | Jun 12, 2023 |
| 8-K/A |
Amended current report
Shareholder vote results
|
Jun 15, 2023 | Jun 12, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jun 13, 2023 | Jun 12, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2023 | Jun 12, 2023 |
| 4 | Insider transaction | May 16, 2023 | May 12, 2023 |
| 10-Q | Quarterly report | May 12, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 11, 2023 | May 11, 2023 |
| 4 | Insider transaction | Apr 27, 2023 | Apr 17, 2023 |
| ARS | Annual report to shareholders | Apr 21, 2023 | Dec 31, 2022 |
| DEF 14A | Proxy statement | Apr 17, 2023 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CAPR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1133869
- Former names
- Nile Therapeutics, Inc. (until Nov 20, 2013); SMI PRODUCTS INC (until Sep 19, 2007)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.